Background: Type 2 diabetes mellitus (T2DM) is a multifactorial disease involving genetic and environmental factors. The E23K KCNJ11 gene polymorphism causes KATP canal overactivity, decreases cell membrane depolarization potential, and decreases insulin secretion. E23K polymorphism of the KCNJ11 gene as a risk factor for T2DM. Methods: This study is a case-control study. The subjects of the study were 100 people with T2DM patients as a case group (50 people) and Non-DM subjects with families who did not have a history of T2DM as a control group (50 people). Fasting blood glucose (GDP) was analyzed by spectrophotometry and E23K KCNJ11 gene by polymerase chain reaction fragment length polymorphism (PCR-RFLP). Data were analyzed by statistics. Results: The frequency of AA genotypes in cases was higher than the controls (12% and 8%) (p = 0.001). The frequency of A allele in the case was higher than the control (32% and 18%) (p = 0.017). The risk of T2DM on AA / GA genotypes was 4.75 times higher in cases than controls (p = 0,000, OR 4.75 95% CI 2.01-11.24). The risk of T2DM in A allele was 2.14 times higher in cases than in controls (p = 0.017, OR 2.14, 95% CI 1.11-4.15). Conclusion: E23K polymorphism of the KCNJ11 gene as a risk factor for T2DM in Bengkulu Serawai Tribe.
Introduction
Diabetes mellitus (DM) is caused by interactions between genetic factors and the environment. Diabetes mellitus is also closely related to family history, increase in body mass index, and decreased insulin secretion and insulin work. 1 Globally, DM patients living in cities reach 246 million people and in rural areas, as many as 136 million people. 2 The increase in the incidence of type 2 diabetes mellitus (T2DM) is a metabolic disease characterized by hyperglycemia due to damage to insulin secretion, insulin action, and/or both. 3 Insulin is a hormone produced by β cells of the islets of Langerhans in the pancreas in response to hyperglycemia and plays a central role in regulating blood glucose. 4 Chronic hyperglycemia in ISSN 2598 0580 people with T2DM can lead to failure of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels. 5 The KCNJ11 gene is located on the same chromosome at the locus 11p15.1 only 4.5 kb apart, both of these genes work on the potassium canal in pancreatic β cells. The reaction was carried out by electrophoresis with 3% agarose gel (for 45 minutes, 100 volts) and visualized with ethidium bromide. Cutting results were seen under UV light, namely: GG (wild type) genotype had one band (179 bp), GA genotype had three bands (179 bp, 160 bp, and 19 bp) and AA genotype had two bands (160 bp and 19 bp).
Results
Genotypic frequency distribution in cases was AA (12%), GA (48%) and GG (40%), while in controls were AA (8%), GA (16%) and GG (76%). There were significant differences in genotypic frequency distribution between cases and controls (p = 0.001). The allele frequency distribution in the cases was A (32%) and G (68%), while those in the controls were A (18%) and G (82%). There were significant differences in allele frequency distribution between cases and controls (p = 0.017). Odds ratio test results to determine AA and GA genotypic risk showed a significant relationship between AA and GA genotypes between cases and controls (p = 0,000, OR 4.75 95% IK 2.01-11.24). Likewise, the A allele showed a significant relationship between cases and controls (p = 0.017 OR 2.14 95% IK 1.12-4.15).
Genotypic frequency distribution (AA, GA, GG) and alleles (A and G) in cases and controls can be seen in Table 1 .
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Table 1. Genotypic frequency distribution (AA, GA, GG) and alleles (A and G)
Discussion
The The results of this study indicate that the AA genotype frequency in the cases was higher than the controls (12% and 8%). The study of the E23K KCNJ11 gene polymorphism in Japan at 889 normal individuals and 906 T2DM patients showed that AA genotypic frequency in T2DM patients was higher than Non-DM (14% and 12%), and there was a significant relationship between polymorphism E23K KCNJ11 gene with the risk of developing T2DM (p = 0.004, OR 1.32, 95% IK 1.09-1.60). [7] [8] The results of this study are different from the E23K polymorphism of the KCNJ11 gene in Israel in 843 normal individuals and 573 T2DM patients who showed no significant association between the E23K KCNJ11 gene polymorphism and the risk of T2DM (p = 0.52, OR 1.05, 95% CI 0.90-1.23). [9] [10] [11] [12] The results of this study indicate that the GA genotype frequency in the cases was higher than the controls (48% and 16%). These results differ from ISSN 2598 0580 studies in Chinese Hubei, Israel and Shandong China. The results of this study are the same as the E23K study of KCNJ11 genes in Czechoslovakia, Japan, Germany, Beijing and Palestine which show GA genotype frequency in T2DM patients higher than Non-DM. [13] [14] [15] [16] The frequency of GG genotypes in cases is lower than controls. These results are similar to studies in Japan, Germany, Shanghai China, Beijing, Palestine and Yogyakarta, but different from the frequency of GG genotypes in Chinese Hubei and Shandong China showed that in DMT2 patients it was higher than Non-DM (22% and 15%) and (39% and 35%). [17] [18] [19] [20] The E23K 
Conclusion
It can be concluded that the E23K KCNJ11 gene polymorphism is a DM risk factor in the Bengkulu Serawai Tribe.
